Introduction. Photobiomodulation using low level laser therapy (LLLT-produced by low to mid- powered coherent lasers ranging from 1 mW to 500 mW) has been researched extensively in animal experiments and is shown to enhance nerve healing; however, few clinical studies report effectiveness of photobiomodulation in humans. Recent understanding suggests that LLRT-induced mitochondrial activity leads to increased ATP production, transcription factor induction, pro and anti-inflammatory gene expression causing cell biostimulation, cytokine modulation, growth factors release and increased tissue oxygenation ameliorating nerve injury. This clinical case report aims to highlight clinical nerve injury recovery after LLLT in a 7-year- old girl following a traumatic Gartland type 3 supracondylar fracture of the right humerus sustained in May 2019. Clincal examination of patient NS suggested right median and ulnar axonometsis evidenced by wasting of intrinsic muscles, thenar and clawing of all digits. After undergoing Closed Manual Reduction and K-wiring there was minimal recovery of motor function below the right wrist. Results. Center based physio and occupational therapy was instituted together with home based therapy - NMES (Neuromuscular electrical stimulation) immediately following injury and surgical management. Typically 86-100% of supracondylar fracture associated nerve injuries resolve spontaneously within 6 months with recovery mean time between 2 and 3 months and in this case, there was some recovery (index finger extension) but stagnated at 5 months. At University Malaya Medical Center (UMMC) she underwent 10 sessions of LLLT at the Rehabilitation Medicine clinic, over a 2 week period resulted in remarkable improvement in motor function especially wrist extension (beyond 90 degrees), extension of 3rd to 5th fingers and 5th finger abduction. Conclusion. Our findings suggest that a structured, intensive course of LLLT has the potential to enhance nerve recovery. Further research is required to determine the duration, intensity and dosage of LLLT to streamline prescription and clinical outcomes.